Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $131.26 USD
Change Today +5.07 / 4.02%
Volume 3.7M
VRTX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Mexico
Frankfurt
As of 5:20 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Matthew W. Emmens

Former Executive Director and Member of Science & Technology Committee, Vertex Pharmaceuticals Incorporated
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 5 different industries.

63--

Background*

Mr. Matthew W. Emmens, also known as Matt, serves as Chief Executive Officer of Shire Pharmaceuticals Group plc. Mr. Emmens served as the Chief Executive Officer of Vertex Pharmaceuticals Incorporated from May 23, 2009 to February 1, 2012, and served as its President from February 2009 to February 1, 2012. Mr. Emmens served as the Chief Executive Officer of Shire plc from March 12, 2003 to June 18, 2008. He joined Shire in 2003 and was based in Darmstadt, Germany as ...

Read Full Background

Corporate Headquarters*

50 Northern Avenue
Boston, Massachusetts 02210

United States

Phone: 617-341-6100
Fax: --

Board Members Memberships*

Prior
2004-N/A
Former Executive Director and Member of Science & Technology Committee
2006-2009
Former Director and Member of Audit Committee
2008-2014
Former Non-Executive Chairman and Member of Nomination Committee

Education*

BS
Fairleigh Dickinson University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRTX:US $131.26 USD +5.07

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$854.7K
Jean-Jacques Bienaime MBAChairman and Chief Executive Officer
BioMarin Pharmaceutical Inc.
$916.0K
Rakesh Sachdev Chief Executive Officer, President and Director
Sigma-Aldrich Corporation
$1.0M
Herve Hoppenot Chief Executive Officer, President, Director and Member of Non-Management Stock Option Committee
Incyte Corporation
$2.9M
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$830.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERTEX PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.